We are a dynamic interdisciplinary research team based in the city of Nicosia, Cyprus. Our diverse team brings together a wide range of expertise, including specialists in Drug Repurposing, Molecular and Behavioral Pharmacology, Drug Discovery, Neuroscience, Clinical Psychology, Medicinal Chemistry, and Systems Bioinformatics. Our lab has four main research units:

• Translational Neuropharmacology
• Clinical Neuropsychopharmacology
• Systems Bioinformatics
• Genetic Epidemiology

Embracing innovation, we integrate experimental techniques, including in vitro, ex vivo, and in vivo rodent models, along with bioinformatics methodologies and genetic epidemiology, to unravel the complexities of different brain diseases, and other comorbid conditions. Our specific focus lies on neurodegenerative and neurodevelopmental diseases, as well as neuropsychiatric disorders. Notably, we are the first lab to ever conduct a drug-interventional clinical trial in Cyprus, marking a significant milestone in our research efforts. In this trial, we are repurposing the anesthetic drug ketamine for treating opioid use disorders (EudraCT number, 2022-001997-70).

In our quest for a healthier future, we go beyond traditional approaches. Our mission extends to exploring the potential of drug repurposing, leveraging the vast knowledge within our team to identify novel solutions for complex conditions. By combining our strengths in diverse fields, we aim to drive innovation and advance our understanding of these intricate disorders.

Our lab is open to new collaborations and welcomes the opportunity to work together with like-minded researchers and organizations. If you share an interest in our lab’s work and envision potential for collaboration, we’d be thrilled to explore new avenues for research and innovation, including the promising realm of drug repurposing. Together, let’s pave the way for transformative discoveries and contribute to the evolving landscape of neuropharmacology research.